Abpro Holdings, Inc.
ABP.US | Research and experimental development on natural sciences and engineering
Abpro Holdings, Inc. is a biotechnology company focused on developing antibody therapies for oncology, autoimmune, and infectious diseases. They utilize their DiversImmune™ platform to discover and develop novel antibody candidates. Their pipeline includes preclinical and clinical-stage programs tar...Show More
Better Health for All
40
Abpro Holdings, Inc. is a biotechnology company entirely focused on developing antibody therapies for serious diseases, including oncology, autoimmune, infectious diseases, and ophthalmology.
1
Its entire business is devoted to health improvement, with no evidence of products or activities having negative health outcomes.
2
The company raised $10 million in gross proceeds, explicitly stating the purpose of this financing is to advance next-generation antibody therapies for cancer, ophthalmology, and infectious diseases, indicating that 100% of this capital allocation is aimed at improving health outcomes.
3
Fair Money & Economic Opportunity
0
Abpro Holdings, Inc. is a biotechnology company focused on developing antibody therapies.
1
The provided articles confirm its core business activities are in biotech research and development, partnerships, and financial market performance. There is no evidence that the company offers lending, insurance, money movement, or storage services, nor any other financial products or services to consumers or businesses. Therefore, all Key Performance Indicators related to 'Fair Money & Economic Opportunity' are not applicable to its operations.
Fair Pay & Worker Respect
-20
The company's overall employee rating on Glassdoor is 2.7 out of 5 stars, which translates to 54/100.
1
Additionally, 42% of employees would recommend working at the company to a friend, and 38% approve of the CEO.
2
Indeed.com reviews also indicate an overall rating of 2.0 out of 5 stars and a culture rating of 2.0 out of 5 stars.
3
Employee reviews mention concerns such as 'missed payroll' and 'salaries well below industry standards'.
4
Fair Trade & Ethical Sourcing
0
No information regarding Abpro Holdings, Inc.'s fair trade and ethical sourcing practices, supply chain audits, forced or child labor incidents, supply chain traceability, remediation processes, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend was found in the provided articles.
1
Honest & Fair Business
-60
The company will restate financial statements for the fiscal year ending December 31, 2022, and the quarters ending December 31, 2023, and September 30, 2024.
1
These three restatements are due to an understated liability of $3.3 million for each affected period, resulting in an average of one restatement per year over the past three years.
2
The company does not have an anti-corruption policy. Furthermore, less than 10% of ethical claims are independently verified, with the Audit Committee and management communicating these issues to Wolf & Company, P.C., the company’s independent registered public accounting firm.
3
Kind to Animals
0
No information was found in the provided articles regarding Abpro Holdings, Inc.'s practices or policies related to animal welfare.
1
Specifically, there is no data on cruelty-free certifications, alternative testing methods, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits, cage-free sourcing, animal testing policy or volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement on animal welfare.
2
No War, No Weapons
0
Abpro Holdings, Inc. is described as a biotechnology company focused on developing antibody therapies for oncology, autoimmune, and infectious diseases.
1
The provided articles detail its business combination, financing, and pipeline advancements for these therapeutic areas. No evidence was found in any of the articles to suggest that the company is involved in arms manufacturing, military contracts, dual-use technology, sales to embargoed regimes, peacebuilding initiatives, or any other activities related to the 'No War, No Weapons' ethical value. Therefore, all KPIs are scored as N/A, indicating no defense or arms-related activities in its core business or operations.
Planet-Friendly Business
0
No data relevant to Planet-Friendly Business KPIs was found in the provided articles. The articles focus on Abpro Holdings, Inc.'s business, pipeline, financing, and institutional holdings, without mentioning any environmental, social, or governance (ESG) metrics or initiatives.
Respect for Cultures & Communities
0
No specific evidence was found in the provided articles regarding ABP.US's performance on any of the KPIs related to Respect for Cultures & Communities. The articles discuss general Diversity, Equity, and Inclusion (DEI) metrics or career opportunities at ABP, but do not contain quantitative data or specific actions taken by the company concerning formal partnerships, community investment, cultural incidents, impact assessments, local employment, grievance mechanisms, FPIC processes, community governance, cultural preservation, local procurement, indigenous suppliers, cultural site protection, social license, charitable giving, community funds, language inclusivity, cultural incident response, or cultural sensitivity training.
1
Safe & Smart Tech
0
No specific, concrete evidence was found in the provided articles to assess Abpro Holdings, Inc. (ABP.US) against any of the Key Performance Indicators for the 'Safe & Smart Tech' ethical value. The articles primarily focus on financial performance, clinical trials, and general corporate governance. While regulatory compliance is mentioned for ABP.US, the details provided relate to financial and operational regulations (e.g., SEC filings, FDA regulations, Nasdaq listing rules, anti-corruption laws) rather than privacy-specific regulations like GDPR or CCPA, which are the focus of the 'regulatory_compliance' KPI for this value.
1
Information regarding privacy practices, certifications, or security measures for 'ABP UK' is explicitly stated as not pertaining to ABP.US.
2
Zero Waste & Sustainable Products
0
No information was found in the provided articles regarding Abpro Holdings, Inc.'s performance on any of the 'Zero Waste & Sustainable Products' KPIs, including waste diversion rates, product recyclability, packaging sustainability, or waste reduction initiatives.
1